GCG and obesity due to melanocortin 4 receptor deficiency: GLP-1 Receptor Agonists (GLP-1 RAs) are a group of medications used to treat type 2 diabetes and obesity by mimicking the incretin hormone GLP-1, thereby promoting blood glucose reduction and weight loss, along with providing added advantages such as lowering cardiovascular and renal risk.